--> -->
简中
ENG
Sinovac
Sinovac
Sinovac at Glance
Our History
Company Culture
Social Responsibilities
News
News
Press Releases
Social Media
Image and Video Library
Products
Products
Vaccines
Logistics Distribution
International Business
Product Consultation
Innovation
Innovation
R&D; Platform
Pipeline Products
Scientific Achievements
Our Partners
Quality
Quality
QMS System
Quality Certification
Investor
Investor
Company Profile
Corporate Governance
- Board of Directors
- Management
Stock Information
Financial Reports
SEC Filings
Events & Presentations
Career
Career
Our Talent
Join us
Sinovac academy
Contact Us
简中
ENG
All
Title
Content
Content+Title
Sinovac
Sinovac at Glance
Our History
Company Culture
Social Responsibilities
News
Press Releases
Social Media
Image and Video Library
Products
Vaccines
Logistics Distribution
International Business
Product Consultation
Innovation
R&D; Platform
Pipeline Products
Scientific Achievements
Our Partners
Quality
QMS System
Quality Certification
Investor
Company Profile
Corporate Governance
Stock Information
Financial Reports
SEC Filings
Events & Presentations
Career
Our Talent
Join us
Sinovac academy
Contact Us
扫码关注科兴官方微信号“疫苗之益”
Home
Products
Vaccines
Vaccines
COVID-19 Vaccine (Vero Cell), Inactivated - CoronaVac®
Conditioned market authorization in China on February 5, 2021 l The results of pre-clinical and clinical research trials were published in Science and The Lancet. l The Phase Ⅲ an
View more
Enterovirus Type 71 Vaccine (Vero cell), Inactivated - Inlive®
Launched in 2016lA new drug under “Category 1 Preventative Biological Products”, and the first of its kind in the world, is being developed, marking a milestone in the transformation of Chinese vaccin
View more
Hepatitis A Vaccine (Human Diploid Cell), Inactivated - Healive®
Launched in 2002Hepatitis A & Hepatitis B Combined Vaccine - Bilive®Launched in 2005l China’s only WHO pre-qualified hepatitis A vaccinel An inactivated hepatitis A vaccine. It is the most widely
View more
Influenza Vaccine (Split Virion), Inactivated - Anflu®
fluenza Vaccine (Split Virion), Inactivated, QuadrivalentPandemic Influenza Vaccine (Inactivated, Adjuvanted)- Panflu®H1N1 Influenza A Vaccine (Split Virion), Inactivated - Panflu.1®l Sinovac has the
View more
23-Valent Pneumococcal Polysaccharide Vaccine
Launched in 2020l Five “technical routes” and precise purification schemes to protect the integrity of antigensl Two innovative chromatographic processes to efficiently remove impuritiesl Preservative
View more
Varicella Vaccine, Live
Launched in 2020l The only new-generation varicella vaccine backed by evidence in phase III clinical efficacy resultsl Protective efficacy of 89.2% against breakthrough cases, and 100% against moderat
View more
Mumps Vaccine, Live
Launched in 2012l No antibiotics added throughout the production processl Seroconversion rate increased to 88.9% after 1 dose of the booster vaccine
View more